Exact Sciences (NASDAQ: EXAS) rallied nearly 20% on November 20 after Abbott Laboratories (NYSE: ABT) announced a $21 billion all-cash deal to acquire the molecular diagnostics company.The transaction that values EXAS shares at $105 each gives ABT a foothold in the rapidly growing cancer diagnostics market through Exact’s flagship products…
Markets were mixed today as global data and policy shifts shaped sentiment. In the US, job growth surprised to…
Asian semiconductor stocks faced sharp declines on Friday after Nvidia’s unexpected drop on Wall Street triggered a broad sector-wide…
Japan’s cabinet on Friday approved a sweeping ¥21.3 trillion ($135.5 billion) stimulus package aimed at bolstering economic growth, easing…
Global economic developments unfolded across multiple regions on Friday, with US banks altering their support strategy for Argentina, Japan…
India’s economic activity showed early signs of cooling in November as global trade tensions began to filter into domestic…
Physical gold demand across major Asian markets remained notably weak this week, a direct consequence of pronounced volatility in…
The United States has reversed its hefty tariffs on Brazilian food products, marking a major shift in how the…
Despite a stronger-than-anticipated increase in US jobs growth for September, the unemployment rate also climbed as more workers entered…